TELADOC HEALTH, INC. Revenues
TELADOC HEALTH, INC. (TDOC) reported Revenues of $629.24 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-02.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2023-05-02
- TELADOC HEALTH, INC. revenues for the quarter ending 2023-03-31 was $629.24M, a 11.30% increase year-over-year.
- TELADOC HEALTH, INC. revenues for the quarter ending 2022-03-31 was $565.35M.
- TELADOC HEALTH, INC. revenues for the quarter ending 2018-12-31 was $122.74M, a 59.11% increase year-over-year.
- TELADOC HEALTH, INC. revenues for the quarter ending 2018-09-30 was $110.96M, a 61.63% increase year-over-year.
- TELADOC HEALTH, INC. revenues for fiscal 2022 was $2.41B, a 18.41% increase from fiscal 2021.
- TELADOC HEALTH, INC. revenues for fiscal 2021 was $2.03B, a 85.81% increase from fiscal 2020.
- TELADOC HEALTH, INC. revenues for fiscal 2020 was $1.09B.
- TELADOC HEALTH, INC. revenues for fiscal 2018 was $417.91M, a 79.14% increase from fiscal 2017.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2023-03-31 | $629.24M 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $2.41B 10-K · filed 2023-03-01 | |||
| 2022-03-31 | $565.35M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $2.03B 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $1.09B 10-K · filed 2023-03-01 | |||
| 2018-12-31 | $122.74M 10-K · filed 2019-02-27 | $233.70M derived: sum of 2 quarters · filed 2019-02-27 | $328.26M derived: sum of 3 quarters · filed 2019-02-27 | $417.91M 10-K · filed 2019-02-27 |
| 2018-09-30 | $110.96M 10-K · filed 2019-02-27 | $205.52M derived: sum of 2 quarters · filed 2019-02-27 | $295.17M 10-Q · filed 2018-11-01 | $372.31M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | $94.56M 10-K · filed 2019-02-27 | $184.20M 10-Q · filed 2018-08-01 | $261.34M derived: sum of 3 quarters · filed 2019-02-27 | $329.99M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | $89.64M 10-K · filed 2019-02-27 | $166.78M derived: sum of 2 quarters · filed 2019-02-27 | $235.43M derived: sum of 3 quarters · filed 2019-02-27 | $280.02M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | $77.14M 10-K · filed 2019-02-27 | $145.79M derived: sum of 2 quarters · filed 2019-02-27 | $190.38M derived: sum of 3 quarters · filed 2019-02-27 | $233.28M 10-K · filed 2019-02-27 |
| 2017-09-30 | $68.65M 10-K · filed 2019-02-27 | $113.24M derived: sum of 2 quarters · filed 2019-02-27 | $156.14M 10-Q · filed 2018-11-01 | $193.54M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $44.59M 10-K · filed 2019-02-27 | $87.49M 10-Q · filed 2018-08-01 | $124.89M derived: sum of 3 quarters · filed 2019-02-27 | $157.27M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $42.90M 10-K · filed 2019-02-27 | $80.30M derived: sum of 2 quarters · filed 2019-02-27 | $112.68M derived: sum of 3 quarters · filed 2019-02-27 | $139.17M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $37.40M 10-K · filed 2018-02-27 | $69.78M derived: sum of 2 quarters · filed 2018-02-27 | $96.27M derived: sum of 3 quarters · filed 2018-02-27 | $123.16M 10-K · filed 2019-02-27 |
| 2016-09-30 | $32.38M 10-K · filed 2018-02-27 | $58.87M derived: sum of 2 quarters · filed 2018-02-27 | $85.76M 10-Q · filed 2017-11-01 | $108.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $26.49M 10-K · filed 2018-02-27 | $53.38M 10-Q · filed 2017-08-02 | $76.02M derived: sum of 3 quarters · filed 2018-02-27 | $95.99M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $26.89M 10-K · filed 2018-02-27 | $49.53M derived: sum of 2 quarters · filed 2018-02-27 | $69.50M derived: sum of 3 quarters · filed 2018-02-27 | $87.78M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $22.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $42.61M derived: sum of 2 quarters · filed 2018-02-27 | $60.90M derived: sum of 3 quarters · filed 2018-02-27 | $77.38M 10-K · filed 2018-02-27 |
| 2015-09-30 | $19.97M 10-Q · filed 2016-10-27 | $38.26M derived: sum of 2 quarters · filed 2016-10-27 | $54.74M 10-Q · filed 2016-10-27 | $67.67M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $18.28M 10-Q · filed 2016-08-03 | $34.77M 10-Q · filed 2016-08-03 | $47.70M derived: sum of 3 quarters · filed 2017-03-01 | $58.60M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $16.49M 10-Q · filed 2016-05-10 | $29.41M derived: sum of 2 quarters · filed 2017-03-01 | $40.32M derived: sum of 3 quarters · filed 2017-03-01 | $50.61M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $12.93M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $23.83M derived: sum of 2 quarters · filed 2017-03-01 | $34.12M derived: sum of 3 quarters · filed 2017-03-01 | $43.53M 10-K · filed 2017-03-01 |
| 2014-09-30 | $10.90M 10-Q · filed 2015-11-02 | $21.19M derived: sum of 2 quarters · filed 2015-11-02 | $30.60M 10-Q · filed 2015-11-02 | |
| 2014-06-30 | $10.29M 10-Q · filed 2015-08-12 | $19.70M 10-Q · filed 2015-08-12 | ||
| 2013-12-31 | $19.91M 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |